NP

Nilesh Prajapati

Active Director Director DIN 07034599
DIN 07034599 First appointment Jan 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2015
Shareholding value •••• Premium profile

About Nilesh Prajapati

Data last updated:

Nilesh Prajapati is a Director at Krosyl Pharmaceuticals Private Limited (since 2015). The company operates in Pharma. Krosyl Pharmaceuticals Private Limited reported revenue of ₹6.32 Cr (FY 2024).

DIN 07034599
Primary Designation Director
Industry Pharma
First Appointment 05 Jan 2015
Oldest Company Age 11 yrs
Largest company Krosyl Pharmaceuticals Private Limited · ₹6.32 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 20152015₹6.32 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Krosyl Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nilesh Prajapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilesh Prajapati

Nilesh Prajapati currently holds 1 directorship: Krosyl Pharmaceuticals Private Limited (Director, since 05 Jan 2015, revenue ₹6.32 Cr (FY 2024)).

Nilesh Prajapati was first appointed on 05 Jan 2015 as Director at Krosyl Pharmaceuticals Private Limited.

The current boards of Nilesh Prajapati's companies include Amit Prabhudas Patel (Krosyl Pharmaceuticals Private Limited), Maulik R Joshi (Krosyl Pharmaceuticals Private Limited), Parth Rameshkumar Joshi (Krosyl Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available